Literature DB >> 27407455

A Two Year Experience in Continuous Positive Airway Pressure Ventilation Using Nasal Prongs and Pulse Oximetry.

R K Malik1, R K Gupta2.   

Abstract

In a prospective study 26 of the 116 consecutive neonates suffering from respiratory distress survived on varying concentrations of humidified oxygen. Continuous positive airway pressure (CPAP) of 4-12 cm of water was applied through short nasal prongs to 90 neonates. Haemoglobin oxygen saturation (SaO2) rose in all and it was maintained steadily above 85% in 46 (51%) infants who survived. The mean duration of CPAP among the survivors was 61 hours (range 8-190 hours). Common indications of CPAP ventilation were hyaline membrane disease (HMD) (27.7%), meconium aspiration syndrome (MAS) (20%), apnea of prematurity (18.8%) and asphyxia (17.7%). Neonates weighing >1000 gm faired well with overall survival of 60 to 82.35%. However, among the 16 babies weighing <1000 gm, only 3 (18.75%) survived. 4 infants on CPAP died due to pneumothorax, none had complications of oxygen toxicity. The 44 CPAP failures, fared poorly even when shifted to intermittent positive pressure ventilation (IPPV) regardless of their weight and 1 among the 5 survivors developed grade 1 intraventricular haemorrhage. It was concluded that nasal CPAP ventilation with pulse oximetry is a simple and efficient method of treating respiratory distress in newborns. This technique can be adopted even by smaller hospitals where the equipment and expertise for IPPV and arterial blood gas (ABG) monitoring are not feasible.

Entities:  

Keywords:  Nasal continuous positive airway pressure; Neonates; Respiratory distress

Year:  2011        PMID: 27407455      PMCID: PMC4925781          DOI: 10.1016/S0377-1237(03)80102-8

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  13 in total

1.  Pulse oximetry: an alternative method for the assessment of oxygenation in newborn infants.

Authors:  M S Jennis; J L Peabody
Journal:  Pediatrics       Date:  1987-04       Impact factor: 7.124

2.  Assisted ventilation with nasal continuous positive airway pressure and its effects on morbidity and mortality in respiratory distress syndrome.

Authors:  H M Risemberg; A K Fomufod; N Hazelbaker; H Nishida; M J Peralta
Journal:  Johns Hopkins Med J       Date:  1974-09

3.  Treatment of the idiopathic respiratory-distress syndrome with continuous positive airway pressure.

Authors:  G A Gregory; J A Kitterman; R H Phibbs; W H Tooley; W K Hamilton
Journal:  N Engl J Med       Date:  1971-06-17       Impact factor: 91.245

4.  The significance of grunting in hyaline membrane disease.

Authors:  V C Harrison; H de V Heese; M Klein
Journal:  Pediatrics       Date:  1968-03       Impact factor: 7.124

5.  Three-year experience with neonatal ventilation from a tertiary care hospital in Delhi.

Authors:  M Singh; A K Deorari; V K Paul; M Mittal; S Shanker; U Munshi; Y Jain
Journal:  Indian Pediatr       Date:  1993-06       Impact factor: 1.411

6.  Neonatal pulmonary ischemia. I. Clinical and physiological studies.

Authors:  J Chu; J A Clements; E K Cotton; M H Klaus; A Y Sweet; W H Tooley; B L Bradley; L C Brandorff
Journal:  Pediatrics       Date:  1967-10       Impact factor: 7.124

7.  Primary causes of neonatal deaths in a tertiary care hospital in Delhi: an autopsy study of 331 cases.

Authors:  M Singh; A K Deorari; V K Paul; M V Murali; M Mathur
Journal:  Ann Trop Paediatr       Date:  1990

8.  Skin craters--a complication of transcutaneous oxygen monitoring.

Authors:  S M Golden
Journal:  Pediatrics       Date:  1981-04       Impact factor: 7.124

9.  Use of nasal continuous positive airway pressure to treat severe recurrent apnoea in very preterm infants.

Authors:  B D Speidel; P M Dunn
Journal:  Lancet       Date:  1976-09-25       Impact factor: 79.321

10.  Pulse oximetry in very low birth weight infants with acute and chronic lung disease.

Authors:  R Ramanathan; M Durand; C Larrazabal
Journal:  Pediatrics       Date:  1987-04       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.